case-study
IV Infusion
Sponsor worked with Frontage on BE/BA study using IV infusion. The product was approved in tablet form however the sponsor was looking to convert the drug into an injectable liquid as a quick on set for the treatment of severe migraines.
Resources to Consider
Duplex Sequencing: A Powerful Tool for In Vivo Gene Mutation
Discover our EMGS 2025 poster showcasing how Duplex Sequencing (ecNGS) reveals the genotox...
poster
BDRP 2025: Comparative Assessment of Dietary Regimens in Rabbit...
Rabbits are commonly used in embryo-fetal development (EFD) studies but are sensitive to i...
poster
AAPS 2024: A GxP-Qualified dPCR-Based RCL Assay to Quantify...
Frontage Laboratories has developed and validated a highly sensitive, GxP-qualified dPCR-b...
poster
Quantitative Assessment of mRNA Drug Biological Activity by...
Biological activity of mRNA drugs, historically assessed via animal study, is critical to ...
poster
A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication...
Lentiviral vectors are widely used in gene and cell therapy for diseases like HIV, cancer,...
poster
Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase...
Oligonucleotides (OGNs) have attracted massive attention as therapeutics due to their abil...
poster
Quantitative Analysis of Antibody Conjugate Payload by LC MS/MS...
Quantitative analysis of ADC free and conjugated payload and its metabolites is critical t...
poster
Genotoxic Potential of an Antiviral Pyrimidine Nucleoside Analogue,...
5-(2-Chloroethyl)-2'-deoxyuridine (CEDU) is a nucleoside analogue developed as an antivira...
